Buspirone is mainly broken down by CYP3A4 in the liver and also affects serotonin. Other medications or substances that change these systems can cause problems.
With: MAOIs (phenelzine, tranylcypromine, isocarboxazid, selegiline, rasagiline)
Risk: Dangerous blood pressure spikes and serotonin toxicity.
Action: Do NOT combine. Wait at least 14 days between stopping an MAOI and starting buspirone (and vice versa).
With: Linezolid or IV Methylene Blue
Risk: Higher risk of serotonin syndrome.
Action: Avoid if possible. If absolutely needed, close monitoring is required.
With: SSRIs, SNRIs, triptans, other serotonergic agents
Risk: Serotonin syndrome (especially with higher doses or multiple serotonin drugs).
Action: Can be used together with careful monitoring. Report symptoms like agitation, shaking, or fever.
With: Strong CYP3A4 inhibitors (nefazodone, certain azole antifungals, some HIV meds, some macrolide antibiotics)
Risk: Higher buspirone levels; more side effects (dizziness, nausea, serotonin symptoms).
Action: Start with very low buspirone doses (often 2.5 mg once or twice daily) and titrate slowly.
With: Strong CYP3A4 inducers (carbamazepine, rifampin, St. John’s wort)
Risk: Lower buspirone levels and reduced effect.
Action: May require higher doses or choosing another anxiety treatment.
With: Alcohol and other CNS depressants
Risk: More dizziness, drowsiness, and impaired coordination.
Action: Best to minimize or avoid, especially when starting or increasing dose.
With: Grapefruit juice
Risk: Raises buspirone blood levels and side effect risk.
Action: Avoid large amounts of grapefruit products.